Since LN18 cells express high levels of S1P5, for which a role in survival of GBM patients has been suggested [16], and to a minor extent expresses S1P1 and S1P2, proliferative effects of S1P via S1P1-3 could be counteracted by S1P5. Here, S1PR2 is linked to glioblastoma.